Sviluppo di modelli preclinici innovativi ex vivo per lo studio dei sarcomi e delle metastasi da tumori solidi (PREMOD)

Title

Code

PREMOD

Type

Sperimentale

Start Year

2024

Status

In Corso

Principal Investigator

051-6366102

toni.ibrahim@ior.it

Ibrahim Toni, BSc, MSc, MD, PhD

Director

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies

Operational unit that carry out the study

complex unit

Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative

Director

Ibrahim Toni, BSc, MSc, MD, PhD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. PREMOD

Wednesday 25 September 2024, 16:42

PG0013879_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Sviluppo di modelli preclinici innovativi ex vivo per lo studio dei sarcomi e delle metastasi da tumori solidi (PREMOD)

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in